Table 1.
The total number of PSD-95-positive puncta in the dorsal raphe of Ovx monkeys treated with placebo, E, P or E+P (n = 3/group).
Set | Ovx | E | P | E+P | F-values |
---|---|---|---|---|---|
1 | 13294133 | 18746336 | 18559261 | 19817792 | |
2 | 13621572 | 17031957 | 17718689 | 20687377 | |
3 | 6590748 | 8127561 | 9514303 | 7161746 | |
11168818 ± 2290986 | 14635285 ± 3291283* | 15264084 ± 2885113* | 15888972 ± 4370827* | F(3,11) = 5.08, P < 0.05 |
The number of puncta for PSD-95 was totaled for 4 anatomical levels, generating one overall total per monkey. Tissue for PSD-95 was processed in 3 different sets containing 1 animal of each treatment group. Sets 1 and 2 were conducted simultaneously, whereas Set 3 was conducted a year later when additional monkeys were obtained. Data values in bold are mean±SEM. There was a significant difference between groups in the total number of puncta (ANOVA for matched samples P = 0.0438).
E, P and E+P greater than Ovx with Newman–Keul’s, P<0.05 all.